Brufsky, A M: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Concurrent sequencing of full-dose CMF chemotherapy and radiation therapy in early breast cancer has no effect on treatment delivery

C. Faul, A. Brufsky, K. Gerszten, J. Flickinger, A. Kunschner, H. Jacob, V. Vogel

Journal:

European Journal of Cancer

Year:

2003

Language:

english

File:

PDF, 131 KB

english, 2003

52

Concurrent sequencing of full dose CMF chemotherapy and radiation therapy in early breast cancer

C. Faul, H. Jacob, K. Gerszten, J. Flickinger, A. Brufsky, A. Kunschner, V. Vogel

Journal:

European Journal of Cancer

Year:

1999

Language:

english

File:

PDF, 133 KB

english, 1999

53

Adjuvant bisphosphonates for early-stage breast cancer

Journal:

The Lancet Oncology

Year:

2011

Language:

english

File:

PDF, 121 KB

english, 2011

54

Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial

Alexander HG Paterson, Stewart J Anderson, Barry C Lembersky, Louis Fehrenbacher, Carla I Falkson, Karen M King, Lorna M Weir, Adam M Brufsky, Shaker Dakhil, Thomas Lad, Luis Baez-Diaz, Julie R Gralow

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 317 KB

english, 2012

55

Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men

Stephen J. Winters, , Adam Brufsky, Joel Weissfeld, Donald L. Trump, Mary Ann Dyky, Venus Hadeed

Journal:

Year:

2001

Language:

english

File:

PDF, 71 KB

english, 2001

56

A phase I trial evaluating the safety and immunogenicity of a HER-2 protein vaccine in patients with breast cancer

B Overmoyer, A Brufsky, B Volck, D Leach, A Oestergaard

Journal:

European Journal of Cancer Supplements

Year:

2004

Language:

english

File:

PDF, 174 KB

english, 2004

57

2007 POSTER Recommendations for the prevention of aromatase inhibitor-associated bone loss in women with breast cancer

M.S. Aapro, P. Hadji, A. Brufsky, M. Tubiana-Hulin, T. Guise, J.J. Body

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 63 KB

english, 2007

58

First-line treatment of metastatic breast cancer: current strategies and emerging systemic therapies

Journal:

Community Oncology

Year:

2010

Language:

english

File:

PDF, 103 KB

english, 2010

59

Ixabepilone in advanced breast cancer: clinical, treatment, and cost-related studies

Journal:

Community Oncology

Year:

2011

Language:

english

File:

PDF, 105 KB

english, 2011

60

Understanding the estrogen receptor signaling pathway: focus on current endocrine agents for breast cancer in postmenopausal women

Adam M. Brufsky

Journal:

Community Oncology

Year:

2011

Language:

english

File:

PDF, 287 KB

english, 2011

61

The beginning of small molecule therapy for endocrine-resistant metastatic breast cancer?

Journal:

Community Oncology

Year:

2011

Language:

english

File:

PDF, 57 KB

english, 2011

62

New antiresorptive agents in metastatic breast cancer: an advance or more of the same?

Journal:

Community Oncology

Year:

2011

Language:

english

File:

PDF, 75 KB

english, 2011

63

Adjuvant treatment of HER2-positive breast cancer: winning efforts continue to improve HER2-positive patient outcome long-term

Rachel C Jankowitz, Adam M Brufsky

Journal:

Breast Cancer Research

Year:

2012

Language:

english

File:

PDF, 92 KB

english, 2012

64

Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment?

Richard A Steinman, Adam M Brufsky, Steffi Oesterreich

Journal:

Breast Cancer Research

Year:

2012

Language:

english

File:

PDF, 234 KB

english, 2012

65

Cancer treatment-induced bone loss in premenopausal women: A need for therapeutic intervention?

P. Hadji, M. Gnant, J.J. Body, N.J. Bundred, A. Brufsky, R.E. Coleman, T.A. Guise, A. Lipton, M.S. Aapro

Journal:

Cancer Treatment Reviews

Year:

2012

Language:

english

File:

PDF, 482 KB

english, 2012

66

PCN80 PATIENT PREFERENCES FOR TOXICITIES ASSOCIATED WITH CHEMOTHERAPIES FOR ADVANCED BREAST CANCER

K. Beusterien, J. Grinspan, T. Tencer, A. Brufsky, C. Visovsky

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 57 KB

english, 2011

67

Finasteride and flutamide as potency-sparing androgen-ablative therapy for advanced adenocarcinoma of the prostate

Adam Brufsky, Pam Fontaine-Rothe, Karen Berlane, Patricia Rieker, Michael Jiroutek, Irving Kaplan, Donald Kaufman, Philip Kantoff

Journal:

Year:

1997

Language:

english

File:

PDF, 600 KB

english, 1997

68

Antitumor properties of bisphosphonates and possible prevention of bone metastases in breast cancer

R. Burkinshaw, A. Brufsky, R. Coleman

Journal:

European Journal of Cancer Supplements

Year:

2008

Language:

english

File:

PDF, 56 KB

english, 2008

69

5016 Efficacy in patient subgroups in RIBBON-1, a randomized, double-blind, Phase III trial of chemotherapy with or without bevacizumab (B) for first-line treatment of HER2-negative locally recurrent or metastatic breast cancer (MBC)

V. Dieras, J. Glaspy, A. Brufsky, I. Bondarenko, O. Lipatov, E.A. Perez, S. Chan, X. Zhou, S.C. Phan, N. Robert

Journal:

European Journal of Cancer Supplements

Year:

2009

Language:

english

File:

PDF, 49 KB

english, 2009

70

476 PFS by patient subgroup for standard chemotherapies in combination with bevacizumab (BV) in the first-line treatment of HER2-negative locally recurrent (LR) or metastatic breast cancer (mBC): results from RIBBON-1

I. Bondarenko, J. Glaspy, A. Brufsky, O. Lipatov, E.A. Perez, S. Chan, X. Zou, S.C. Phan, N.J. Robert, V. Dieras

Journal:

European Journal of Cancer Supplements

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

71

469 Incidence of selected adverse events (AEs) in phase III studies of bevacizumab (BV) in combination with chemotherapy for the treatment of HER2-negative metastatic breast cancer (mBC)

D.W. Miles, V. Dieras, J. Glaspy, A. Brufsky, P. Koralewski, S.C. Phan, N.J. Robert

Journal:

European Journal of Cancer Supplements

Year:

2010

Language:

english

File:

PDF, 49 KB

english, 2010

72

485 Influence of disease free interval on the efficacy of capecitabine-bevacizumab for HER2-negative metastatic breast cancer (MBC) in the RIBBON-1 trial

A. Brufsky, O. Ponomarova, S. Tjulandin

Journal:

European Journal of Cancer Supplements

Year:

2010

Language:

english

File:

PDF, 49 KB

english, 2010

73

489 Bevacizumab (BV) in combination with chemotherapy in the treatment of HER2-negative metastatic breast cancer (mBC): PFS subgroup results from two phase III studies

J. Glaspy, V. Dieras, A. Brufsky, D.W. Miles, S.C. Phan, J. O'Shaughnessy

Journal:

European Journal of Cancer Supplements

Year:

2010

Language:

english

File:

PDF, 48 KB

english, 2010

74

Hormone Receptor Status Does Not Affect the Clinical Benefit of Trastuzumab Therapy for Patients with Metastatic Breast Cancer

Adam Brufsky, Barry Lembersky, Kathy Schiffman, Grazyna Lieberman, Virginia E. Paton

Journal:

Clinical Breast Cancer

Year:

2005

Language:

english

File:

PDF, 505 KB

english, 2005

75

RiBBON 1 and RiBBON 2: Phase III Trials of Bevacizumab with Standard Chemotherapy for Metastatic Breast Cancer

Joyce A. O'Shaughnessy, Adam M. Brufsky

Journal:

Clinical Breast Cancer

Year:

2008

Language:

english

File:

PDF, 88 KB

english, 2008

76

Phase II Trial of Weekly Nanoparticle Albumin-Bound Paclitaxel With Carboplatin and Trastuzumab as First-line Therapy for Women With HER2-Overexpressing Metastatic Breast Cancer

Alison K. Conlin, Andrew D. Seidman, Ariadne Bach, Diana Lake, Maura Dickler, Gabriella D'Andrea, Tiffany Traina, Michael Danso, Adam M. Brufsky, Mansoor Saleh, Alicia Clawson, Clifford A. Hudis

Journal:

Clinical Breast Cancer

Year:

2010

Language:

english

File:

PDF, 1.03 MB

english, 2010

77

Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer

Bear, Harry D., Tang, Gong, Rastogi, Priya, Geyer, Charles E., Robidoux, André, Atkins, James N., Baez-Diaz, Luis, Brufsky, Adam M., Mehta, Rita S., Fehrenbacher, Louis, Young, James A., Senecal, Fran

Journal:

Boston Medical and Surgical Journal

Year:

2012

Language:

english

File:

PDF, 605 KB

english, 2012

78

Precision Oncology in Breast Cancer: Better than Ever, or Less than Before?

Journal:

The Breast Journal

Year:

2013

Language:

english

File:

PDF, 39 KB

english, 2013

79

Long-term Treatment with Intravenous Bisphosphonates in Metastatic Breast Cancer: A Retrospective Study

Brufsky, Adam M., Sereika, Susan M., Mathew, Aju, Tomifumi, Onishi, Singh, Vikramjit, Rosenzweig, Margaret

Journal:

The Breast Journal

Year:

2013

Language:

english

File:

PDF, 114 KB

english, 2013

80

Definitive Results of a Phase III Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Operable, Node-Positive Breast Cancer: The NSABP B-38 Trial

Swain, S. M., Tang, G., Geyer, C. E., Rastogi, P., Atkins, J. N., Donnellan, P. P., Fehrenbacher, L., Azar, C. A., Robidoux, A., Polikoff, J. A., Brufsky, A. M., Biggs, D. D., Levine, E. A., Zapas, J.

Journal:

Journal of Clinical Oncology

Year:

2013

Language:

english

File:

PDF, 777 KB

english, 2013

81

Treatment of HER2-positive breast cancer: looking backwards briefly

Puhalla, Shannon, Brufsky, Adam

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 218 KB

english, 2013

82

Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer

Rugo, Hope S., Brufsky, Adam M., Yood, Marianne Ulcickas, Tripathy, Debu, Kaufman, Peter A., Mayer, Musa, Yoo, Bongin, Abidoye, Oyewale O., Yardley, Denise A.

Journal:

Breast Cancer Research and Treatment

Year:

2013

Language:

english

File:

PDF, 428 KB

english, 2013

83

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer

Lin, N. U., Dieras, V., Paul, D., Lossignol, D., Christodoulou, C., Stemmler, H.-J., Roche, H., Liu, M. C., Greil, R., Ciruelos, E., Loibl, S., Gori, S., Wardley, A., Yardley, D., Brufsky, A., Blum, J

Journal:

Clinical Cancer Research

Year:

2009

Language:

english

File:

PDF, 368 KB

english, 2009

84

How to Develop and Deliver Pathway-Based Care

Brufsky, Adam, Lokay, Kathleen

Journal:

Hematology/Oncology Clinics of North America

Year:

2013

Language:

english

File:

PDF, 301 KB

english, 2013

85

Persistent pain in postmastectomy patients: Comparison of psychophysical, medical, surgical, and psychosocial characteristics between patients with and without pain

Schreiber, Kristin L., Martel, Marc O., Shnol, Helen, Shaffer, John R., Greco, Carol, Viray, Nicole, Taylor, Lauren N., McLaughlin, Meghan, Brufsky, Adam, Ahrendt, Gretchen, Bovbjerg, Dana, Edwards, R

Journal:

Year:

2013

Language:

english

File:

PDF, 318 KB

english, 2013

86

Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER

Yardley, D A, Tripathy, D, Brufsky, A M, Rugo, H S, Kaufman, P A, Mayer, M, Magidson, J, Yoo, B, Quah, C, Ulcickas Yood, M

Journal:

British Journal of Cancer

Year:

2014

Language:

english

File:

PDF, 706 KB

english, 2014

87

Recommandations aux auteurs

Journal:

Science & Sports

Year:

1988

Language:

french

File:

PDF, 85 KB

french, 1988

88

Phase II Trial Evaluating the Palliative Benefit of Second-Line Zoledronic Acid in Breast Cancer Patients With Either a Skeletal-Related Event or Progressive Bone Metastases Despite First-Line Bisphosphonate Therapy

Journal:

Breast Diseases: A Year Book Quarterly

Year:

2007

Language:

english

File:

PDF, 60 KB

english, 2007

89

Using Mice to Treat (Wo)men: Mining Genetic Changes in Patient Xenografts to Attack Breast Cancer

Oesterreich, Steffi, Brufsky, Adam M., Davidson, Nancy E.

Journal:

Year:

2013

Language:

english

File:

PDF, 59 KB

english, 2013

90

The bone substudy of MA.27: does bone make a difference?

Mathew, Aju, Brufsky, Adam

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 238 KB

english, 2014

91

RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer

Journal:

Breast Diseases: A Year Book Quarterly

Year:

2011

Language:

english

File:

PDF, 99 KB

english, 2011

92

Elevated Bone Turnover Predicts for Bone Metastasis in Postmenopausal Breast Cancer: Results of NCIC CTG MA.14

Journal:

Breast Diseases: A Year Book Quarterly

Year:

2012

Language:

english

File:

PDF, 55 KB

english, 2012

93

Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients

Jankowitz, R.C., Brufsky, A.M.

Journal:

Breast Diseases: A Year Book Quarterly

Year:

2009

Language:

english

File:

PDF, 87 KB

english, 2009

94

Therapeutic approaches for HER2-positive brain metastases: Circumventing the blood–brain barrier

Mehta, Ankit I., Brufsky, Adam M., Sampson, John H.

Journal:

Cancer Treatment Reviews

Year:

2013

Language:

english

File:

PDF, 574 KB

english, 2013

95

The CAG Repeat within the Androgen Receptor Gene and its Relationship to Prostate Cancer

Edward Giovannucci, Meir J. Stampfer, Krishna Krithivas, Myles Brown, Adam Brufsky, James Talcott, Charles H. Hennekens and Philip W. Kantoff

Journal:

Proceedings of the National Academy of Sciences

Year:

1997

Language:

english

File:

PDF, 724 KB

english, 1997

96

Bisphosphonates in breast cancer

Mathew, Aju, Brufsky, Adam

Journal:

International Journal of Cancer

Year:

2015

Language:

english

File:

PDF, 185 KB

english, 2015

97

Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer

Yardley, Denise A., Kaufman, Peter A., Brufsky, Adam, Yood, Marianne Ulcickas, Rugo, Hope, Mayer, Musa, Quah, Cheng, Yoo, Bongin, Tripathy, Debu

Journal:

Breast Cancer Research and Treatment

Year:

2014

Language:

english

File:

PDF, 507 KB

english, 2014

98

RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative, Locally Recurrent or Metastatic Breast Cancer

Robert, N. J., Dieras, V., Glaspy, J., Brufsky, A. M., Bondarenko, I., Lipatov, O. N., Perez, E. A., Yardley, D. A., Chan, S. Y. T., Zhou, X., Phan, S.-C., O'Shaughnessy, J.

Journal:

Journal of Clinical Oncology

Year:

2011

Language:

english

File:

PDF, 317 KB

english, 2011

99

Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study

Peter A. Kaufman,Adam M. Brufsky,Musa Mayer…

Journal:

Breast Cancer Research and Treatment

Year:

2012

Language:

english

File:

PDF, 268 KB

english, 2012

100

Breast cancer: Zoledronic acid—more than just a bone drug

Mathew, Aju, Brufsky, Adam

Journal:

Nature Reviews Clinical Oncology (formerly Nature Clinical Practice Oncology)

Year:

2014

Language:

english

File:

PDF, 571 KB

english, 2014

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски